Cargando…
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Successful pancreatic ductal adenocarcinoma (PDAC) immunotherapy necessitates optimization and maintenance of activated effector T cells (Teff). We prospectively collected and applied multi-omic analyses to paired pre- and post-treatment PDAC specimens collected in a platform neoadjuvant study of gr...
Autores principales: | Li, Keyu, Tandurella, Joseph A., Gai, Jessica, Zhu, Qingfeng, Lim, Su Jin, Thomas, Dwayne L., Xia, Tao, Mo, Guanglan, Mitchell, Jacob T., Montagne, Janelle, Lyman, Melissa, Danilova, Ludmila V., Zimmerman, Jacquelyn W., Kinny-Köster, Benedict, Zhang, Tengyi, Chen, Linda, Blair, Alex B., Heumann, Thatcher, Parkinson, Rose, Durham, Jennifer N., Narang, Amol K., Anders, Robert A., Wolfgang, Christopher L., Laheru, Daniel A., He, Jin, Osipov, Arsen, Thompson, Elizabeth D., Wang, Hao, Fertig, Elana J., Jaffee, Elizabeth M., Zheng, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669212/ https://www.ncbi.nlm.nih.gov/pubmed/36306792 http://dx.doi.org/10.1016/j.ccell.2022.10.001 |
Ejemplares similares
-
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
por: Heumann, Thatcher, et al.
Publicado: (2023) -
Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy
por: Ho, Won Jin, et al.
Publicado: (2020) -
Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses
por: Jayaraman, Sahana, et al.
Publicado: (2023) -
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
por: Zhang, Shuming, et al.
Publicado: (2023) -
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
por: Zhang, Shuming, et al.
Publicado: (2023)